TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
-1.78%
↑ 96% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-41.86%
Historical baseline
PeriodValue
2025-1.78%
2024-42.91%
2023-34.73%
2022-36.19%
2021-86.11%
2020-91.29%
20190.00%